Capsule Endoscopy Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

The global capsule endoscopy market is projected to grow at a compound annual growth rate (CAGR) of 9.61% from 2024 to 2030. The increasing prevalence of gastrointestinal disorders, such as Crohn's disease, inflammatory bowel disease, colorectal cancer, and esophageal cancer, is significantly driving the demand for capsule endoscopy. Ongoing advancements in product development and technology are expected to further contribute to the market's growth.
DelveInsight's Capsule Endoscopy Market Insights report [https://www.delveinsight.com/report-store/capsule-endoscopy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] provides the current and forecast market analysis, individual leading Capsule Endoscopy companies' market shares, challenges, Capsule Endoscopy market drivers, barriers, and trends, and key Capsule Endoscopy companies in the market.

Key Takeaways from the Capsule Endoscopy Market Report

*
The Capsule Endoscopy market is projected to grow at a moderate CAGR from 2025 to 2032.

*
As per DelveInsight estimates, North America is anticipated to dominate the global Capsule Endoscopy market during the forecast period.

*
Notable Capsule Endoscopy companies such as Medtronic, Olympus Corporation, Intromedic, Jinshan Science & Technology, Fujifilm Holdings America Corporation, CapsoCam Plus Registered , RF Co., Ltd., AnX Robotica, Shangxian Minimal Invasive Inc., Check-Cap, and several others are currently operating in the Capsule Endoscopy market.

*
In January 2025, CapsoVision, Inc. announced that its CapsoCam Plus Registered capsule endoscopy system received FDA approval for remote ingestion, enabling patients to take the capsule at home under virtual medical supervision. This innovation improves accessibility and comfort for small bowel diagnostics.

*
In November 2021, Medtronic received 510(k) clearance for its PillCam Trademark Small Bowel 3 system, allowing for remote endoscopy procedures. Through the PillCam Trademark SB3 @HOME program, Medtronic has partnered with Amazon logistics to deliver accurate results to patients at home, offering a convenient alternative to visiting medical facilities.

*
In January 2021, Philips, a global leader in health technology, entered into an agreement to acquire Capsule Technologies, Inc., a provider of medical device integration and data technologies for healthcare organizations. This acquisition is aimed at enhancing Philips' patient care management capabilities.

To read more about the latest highlights related to the Capsule Endoscopy market, get a snapshot of the key highlights entailed in the Global Capsule Endoscopy Market Report [https://www.delveinsight.com/sample-request/capsule-endoscopy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Capsule Endoscopy Overview

Capsule endoscopy is a non-invasive medical imaging technique used primarily to examine the gastrointestinal (GI) tract, especially areas that are difficult to reach with traditional endoscopic methods, such as the small intestine. This technology involves swallowing a small, pill-sized capsule that contains a camera and light source. The capsule captures images as it travels through the digestive tract, transmitting them wirelessly to a recording device worn by the patient.

Capsule Endoscopy Market Insights

North America is anticipated to hold the largest share of the capsule endoscopy market in 2023 among all regions. This dominance is attributed to the high prevalence of gastrointestinal conditions such as Crohn's disease, inflammatory bowel disease, colorectal cancer, and esophageal cancer.

According to the American Cancer Society, approximately 22,370 new cases of esophageal cancer were diagnosed in the United States in 2024, with 17,690 cases in men and 4,680 in women. Additionally, GLOBOCAN (2024) reported around 184,000 new cases of colorectal cancer in North America in 2021. This substantial disease burden highlights the critical role of capsule endoscopy in supporting healthcare providers with accurate diagnosis and treatment planning. As a result, the growing number of gastrointestinal cases continues to drive market growth in the region.

To know more about why North America is leading the market growth in the Capsule Endoscopy market, get a snapshot of the Capsule Endoscopy Market Outlook [https://www.delveinsight.com/report-store/capsule-endoscopy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Capsule Endoscopy Market Dynamics

According to the latest update from GLOBOCAN in 2024, there were approximately 1.9 million new cases of colorectal cancer globally in 2022, a figure projected to rise to around 2.36 million by 2030, highlighting the growing global burden of the disease. In Europe alone, there were 538,000 new cases reported in 2022, with numbers expected to climb to about 593,000 by 2030. This rising prevalence emphasizes the increasing need for capsule endoscopy, which serves as a valuable complementary tool for assessing suspected colorectal lesions and abnormalities.

Additionally, the capsule endoscopy market is experiencing a significant trend driven by the growing integration of artificial intelligence (AI) into endoscopic procedures. For example, in October 2022, Sheba Medical Center partnered with Intel Corporation to develop an AI algorithm capable of scanning 10,000 to 12,000 digestive system images within just two minutes to aid in the early detection of Crohn's disease. When combined with capsule endoscopy, this AI technology demonstrated a strong diagnostic performance, achieving an 86% accuracy rate in analyzing data and images. These technological advancements, particularly through AI integration, are poised to play a major role in shaping the future of the capsule endoscopy market.

Capsule Endoscopy Market Drivers:

*
Growing prevalence of gastrointestinal disorders

*
Increasing technological advancement

Get a sneak peek at the Capsule Endoscopy market dynamics @ https://www.delveinsight.com/sample-request/capsule-endoscopy-market [https://www.delveinsight.com/sample-request/capsule-endoscopy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Coverage: Global

Study Period: 2022 to 2032

Key Capsule Endoscopy Companies: Medtronic, Olympus Corporation, Intromedic, Jinshan Science & Technology, Fujifilm Holdings America Corporation, CapsoCam Plus Registered , RF Co., Ltd., AnX Robotica, Shangxian Minimal Invasive Inc., Check-Cap, and others.

Which MedTech key players in the Capsule Endoscopy market are set to emerge as the trendsetter, explore @ Capsule Endoscopy Companies [https://www.delveinsight.com/report-store/capsule-endoscopy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Table of Contents

1. Capsule Endoscopy Market Report Introduction

2. Capsule Endoscopy Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Capsule Endoscopy Market Key Factors Analysis

6. Capsule Endoscopy Market Porter's Five Forces Analysis

7. Capsule Endoscopy Market Layout

8. Capsule Endoscopy Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=capsule-endoscopy-market-set-for-steady-expansion-by-2032-driven-by-innovation-and-growing-surgical-volumes-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.